Predictors of skeletal-related events and mortality in men with metastatic, castration-resistant prostate cancer: Results from the Shared Equal Access Regional Cancer Hospital (SEARCH) database.
Ingrid Lorese TablazonLauren E HowardAmanda M De HoedtWilliam J AronsonChristopher J KaneChristopher L AmlingMatthew R CooperbergMartha K TerrisStephen J FreedlandStephen B WilliamsPublished in: Cancer (2019)
Among men with bone mCRPC, bone pain was found to be the strongest predictor of SREs and the number of bone metastases was a strong predictor of mortality. If validated, these factors potentially may be used for risk stratification and for SRE prevention strategies.
Keyphrases
- bone mineral density
- cardiovascular events
- papillary thyroid
- middle aged
- chronic pain
- soft tissue
- squamous cell carcinoma
- small cell lung cancer
- adverse drug
- risk factors
- healthcare
- pain management
- bone loss
- bone regeneration
- postmenopausal women
- neuropathic pain
- type diabetes
- squamous cell
- emergency department
- coronary artery disease
- young adults
- spinal cord
- acute care
- electronic health record
- postoperative pain